Shenzhen Chipscreen Biosciences Co Net debt/EBITDA
Qual é o Net debt/EBITDA de Shenzhen Chipscreen Biosciences Co?
O Net debt/EBITDA de Shenzhen Chipscreen Biosciences Co., Ltd. é 5,565.30
Qual é a definição de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA de empresas na Setor Health Care em SSE em comparação com Shenzhen Chipscreen Biosciences Co
O que Shenzhen Chipscreen Biosciences Co faz?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Empresas com net debt/ebitda semelhantes a Shenzhen Chipscreen Biosciences Co
- Mechel PJSC tem Net debt/EBITDA de 3,412.93
- MAN SE tem Net debt/EBITDA de 3,439.00
- Cresud tem Net debt/EBITDA de 3,527.59
- Dealnet Capital tem Net debt/EBITDA de 3,642.37
- EPI () tem Net debt/EBITDA de 4,336.87
- KT tem Net debt/EBITDA de 4,758.28
- Shenzhen Chipscreen Biosciences Co tem Net debt/EBITDA de 5,565.30
- Aemetis Inc tem Net debt/EBITDA de 6,195.62
- TTL Beteiligungs- und Grundbesitz-AG tem Net debt/EBITDA de 6,283.54
- Prospect Resources tem Net debt/EBITDA de 6,818.24
- Enel Chile S.A tem Net debt/EBITDA de 7,379.66
- Boeing Co tem Net debt/EBITDA de 7,664.71
- SK Telecom Co Ltd tem Net debt/EBITDA de 7,844.35